Literature DB >> 30442758

Different Radionuclides in DOTA-EB-TATE Effect Different Uptake in Somatostatin Receptor-Positive HEK293 Cells.

Jörg Kotzerke1, Roswitha Runge, Anja Braune, Gerd Wunderlich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30442758      PMCID： PMC6910628          DOI： 10.2967/jnumed.118.220707

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  4 in total

1.  Safety, Pharmacokinetics, and Dosimetry of a Long-Acting Radiolabeled Somatostatin Analog 177Lu-DOTA-EB-TATE in Patients with Advanced Metastatic Neuroendocrine Tumors.

Authors:  Jingjing Zhang; Hao Wang; Orit Jacobson; Yuejuan Cheng; Gang Niu; Fang Li; Chunmei Bai; Zhaohui Zhu; Xiaoyuan Chen
Journal:  J Nucl Med       Date:  2018-04-13       Impact factor: 10.057

2.  Carboxyl-terminal multi-site phosphorylation regulates internalization and desensitization of the human sst2 somatostatin receptor.

Authors:  Andreas Lehmann; Andrea Kliewer; Dagmar Schütz; Falko Nagel; Ralf Stumm; Stefan Schulz
Journal:  Mol Cell Endocrinol       Date:  2014-02-22       Impact factor: 4.102

3.  Novel Structural Modification Based on Evans Blue Dye to Improve Pharmacokinetics of a Somastostatin-Receptor-Based Theranostic Agent.

Authors:  Nilantha Bandara; Orit Jacobson; Cedric Mpoy; Xiaoyuan Chen; Buck E Rogers
Journal:  Bioconjug Chem       Date:  2018-07-02       Impact factor: 4.774

4.  Evans Blue Attachment Enhances Somatostatin Receptor Subtype-2 Imaging and Radiotherapy.

Authors:  Rui Tian; Orit Jacobson; Gang Niu; Dale O Kiesewetter; Zhantong Wang; Guizhi Zhu; Ying Ma; Gang Liu; Xiaoyuan Chen
Journal:  Theranostics       Date:  2018-01-01       Impact factor: 11.556
  4 in total
  1 in total

Review 1.  Neuroendocrine neoplasia of the gastrointestinal tract revisited: towards precision medicine.

Authors:  Guido Rindi; Bertram Wiedenmann
Journal:  Nat Rev Endocrinol       Date:  2020-08-24       Impact factor: 43.330
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.